Expired Canadian patentCanada
Pharmaceutical composition comprising t-pa and oxypurinol
CA 1282002 C · Owner: Wellcome Foundation Limited (The) · Inventors: Namm, Donald H.; Frangakis, Crist J.; Berger, Henry, Jr.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A combination of t-PA and oxypurinol of use in inhibiting damage tojeopardized tissue during reperfusion in a mammal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 26, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 26, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 12, 1987
GrantedMarch 26, 1991
Term endedMarch 26, 2008
Patent numberCA 1282002 C
Classification (IPC)A61K31/52 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.